Medcolcanna Organics Inc. (E:MCCN*CA)

Business Focus: Recreational Pharmaceuticals

Jun 01, 2023 01:10 pm ET
Medcolcanna Organics Announces Bridge Loan Arrangement
Bogota, Colombia--(Newsfile Corp. - June 1, 2023) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna," "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, announces a bridge loan arrangement (the "Bridge Loan") with a significant shareholder of the Company (the "Lender"). Under the terms of the Bridge Loan, the Lender provided a bridge loan financing amount of USD$500,000 for a nine month term at an annual interest rate of 12% per annum, with interest payments to begin on January 1, 2024 and with an additional USD$500,000 being available for a period of two months (the "Override Amount"), bringing the total available loan amount to USD$1,000,000. The purpose of the Bridge Loan is to cover working capital requirements, including payroll and related business expenses, until the Company can become financially self-sustaining and to cover some of the costs associated with paying for audit related expenses so that the Company can file its outstanding financial statements and get its shares relisted and reposted for trading on the Canadian Securities Exchange ("CSE"). Final details of the Bridge Loan are subject to acceptance of the CSE.
Mar 07, 2023 08:51 am ET
Medcolcanna Organics Announces Bridge Loan Arrangment
Bogota, Colombia--(Newsfile Corp. - March 7, 2023) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, announces a bridge loan arrangement (the "Bridge Loan") with a significant shareholder of the Company (the "Lender"). Under the terms of the Bridge Loan, the Lender provided a bridge loan financing amount of USD$100,000 for a two-year term at an annual interest rate of 12% per annum, with interest payments completed quarterly with an additional USD$200,000 which was recently borrowed (the "Override Amount"), bringing the total available loan amount to USD$300,000. The purpose of the Bridge Loan is to cover working capital requirements, including payroll and related business expenses, until the Company can become financially self-sustaining and to cover some of the costs associated with paying for audit related expenses so that the Company can file its outstanding financial statements and get its shares relisted and reposted for trading on the Canadian Securities Exchange ("CSE"). Final details of the Bridge Loan are subject to acceptance of the CSE.
Aug 09, 2022 07:00 am ET
Operational and Commercial Update: Medcolcanna Organics Executes Definitive Colombian Supply Agreements and EU Sales Agreements for EUGMP Certified Dried Flower, GAPC Certified Flower and Others
Bogota, Colombia--(Newsfile Corp. - August 9, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of two Definitive Colombian Supply Agreements and two EU Sales Agreements for EUGMP and CUMS-IMC certified Dried Flower. The executed agreements are for the purchase of 1,200 and up to 8,000 kilos per year of indoor grown and EUGMP certified dried flower as well as 800 kilos of CUMS-IMC certified Dried Flower. MCCN has also signed two definitive agreements for the sale of and distribution of the EUGMP and CUMS-IMC certified Dried Flower.
Jul 11, 2022 12:10 pm ET
CSE Bulletin: Suspensions (MCCN, MEAL, WBIO, TELE, GBMC, CBDN)
Toronto, Ontario--(Newsfile Corp. - Le 11 juillet/July 2022) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions.
Jul 11, 2022 07:54 am ET
IIROC Trading Halt - MCCN
VANCOUVER, BC, July 11, 2022 /CNW/ - The following issues have been halted by IIROC:
Jul 06, 2022 07:00 am ET
Medcolcanna Organics Inc. Provides Corporate Update
Bogotá, Colombia--(Newsfile Corp. - July 6, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is announcing certain corporate updates.
Jun 29, 2022 05:00 pm ET
Medcolcanna Organics Inc. Announces Fourth Update to Management Cease Trade Order
Bogotá, Colombia--(Newsfile Corp. - June 29, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is announcing, further to its previous press releases dated May 3, 2022, May 16, 2022, June 2, 2022 and June 14, 2022, that its audited financial report, CEO and CFO certifications, and management discussion & analysis (the "Annual Filings") for the year ended December 31, 2021 were not released as scheduled on or about May 2, 2022. The Company hopes to be able to file the Annual Filings on or about July 15, 2022.
Jun 14, 2022 06:23 pm ET
Medcolcanna Organics Inc. Announces Third Update to Management Cease Trade Order
Bogotá, Colombia--(Newsfile Corp. - June 14, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is announcing, further to its previous press releases dated May 3, 2022, May 16, 2022 and June 2, 2022, that its audited financial report, CEO and CFO certifications, and management discussion & analysis (the "Annual Filings") for the year ended December 31, 2021 were not released as scheduled on or about May 2, 2022. The Company hopes to be able to file the Annual Filings on or about June 30, 2022.
Jun 02, 2022 06:06 pm ET
Medcolcanna Organics Inc. Announces Second Update to Management Cease Trade Order
Bogota, Colombia--(Newsfile Corp. - June 2, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is announcing, further to its previous press releases dated May 3, 2022 and May 16, 2022, that its audited financial report, CEO and CFO certifications, and management discussion & analysis (the "Annual Filings") for the year ended December 31, 2021 were not released as scheduled on or about May 2, 2022. The Company hopes to be able to file the Annual Filings on or about June 30, 2022.
May 16, 2022 08:35 pm ET
Medcolcanna Organics Inc. Announces First Update to Management Cease Trade Order
Bogotá, Colombia--(Newsfile Corp. - May 16, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is announcing, further to its previous press release dated May 3, 2022 that its audited financial report, CEO and CFO certifications, and management discussion & analysis (the "Annual Filings") for the year ended December 31, 2021 were not released as scheduled on or about May 2, 2022. The Company hopes to be able to file the Annual Filings on or about June 15, 2022.
May 03, 2022 06:55 pm ET
Medcolcanna Organics Inc. Announces Corporate Update
Bogotá, Colombia--(Newsfile Corp. - May 3, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, announced today that its audited financial report, CEO and CFO certifications, and management discussion & analysis (the "Annual Filings") for the year ended December 31, 2021 were not released as scheduled on or about May 2, 2022. It is now anticipated that the release will occur on or about June 15, 2022.
Mar 17, 2022 07:00 am ET
Medcolcanna Organics Inc. Announces Closing of Equity Financing
Bogotá, Colombia--(Newsfile Corp. - March 17, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce that it has closed on its previously announcing equity financing of 50,000,000 units in the capital of the Company ("Units") at a price of $0.05 per Unit, with each Unit consisting of one common share in the capital of the Company (each, a "Common Share") and one half of one common share purchase warrant (each, a "Warrant"), each Warrant exercisable into a Common Share at a price of $0.10 per share until the date that is two years from the date of issuance, for total gross proceeds of up to USD$2 million (the "Offering"), being approximately $2.5 million in Canadian dollars. The Offering was non-brokered and is subject to final approval of the Canadian Securities Exchange. A finder's fee in an amount of five percent (5%) of the gross proceeds raised pursuant to the offering was paid to the company that introduced the Company to the investor, such amount to be payable in Units.
Feb 14, 2022 07:00 am ET
Medcolcanna Organics Inc. Announces Equity Financing
Bogotá, Colombia--(Newsfile Corp. - February 14, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce that it intends to complete an offering of up to 50,000,000 units in the capital of the Company ("Units") at a price of $0.05 per Unit, with each Unit consisting of one common share in the capital of the Company (each, a "Common Share") and one half of one common share purchase warrant (each, a "Warrant"), each Warrant exercisable into a Common Share at a price of $0.10 per share until the date that is two years from the date of issuance, for total gross proceeds of up to USD$2 million (the "Offering"), being approximately $2.5 million in Canadian dollars. Closing on an initial tranche is expected to occur in the next few days, with the balance of the Offering to close in the next week or so. The Offering is non-brokered and is subject to approval of the Canadian Securities Exchange. The Company intends to use the proceeds for general working capital as well as the purchase of raw materials for use in the business and to cover manufacturing costs for the Company's products, as well as to pay outstanding trade payables and employee and consultant amounts owing.
Jan 19, 2022 08:30 am ET
Canadian Securities Exchange Reports Record 2021 Performance
Toronto, Ontario--(Newsfile Corp. - January 19, 2022) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced record market statistics for 2021. Trading activity reached record levels, and CSE issuers raised more than $8 billion of aggregate capital, far exceeding any other annual total in the Exchange's history.
Jan 17, 2022 07:15 am ET
Medcolcanna Organics Announces Issuance of Shares Pursuant to Payment of Debenture Interest
Bogotá, Colombia--(Newsfile Corp. - January 17, 2022) - Medcolcanna Organics Inc. (CSE: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, announces that it is issuing a total of 1,595,554 common shares in the capital of the Company ("Common Shares") to the holders of the secured convertible debentures of the Company (the "Debentures") that were issued during fiscal 2020. Pursuant to the terms of the Debentures, interest can be paid either in cash or Common Shares, at the discretion of the Company. In order to conserve cash, the Company has elected to pay the interest owing for the period from July 1, 2021 to December 31, 2021 in Common Shares. The Common Shares are being issued at a price of $0.055 per share, such price being based on the sixty day volume weighted average trading price of the Common Shares on the facilities of the NEO Exchange Inc. up to December 29, 2021 when the Common Shares were delisted from that exchange and for December 30 and 31, 2021 on the facilities of the Canadian Securities Exchange ("CSE"), the exchange on which the Common Shares are currently listed. The issuance of the Common Shares allows the Company to settle certain debt owing to various creditors and preserve its working capital for growing the business as it works towards achieving self-sufficiency and being self-financing. Finalization of the issuance of the Common Shares set forth above is subject to the approval of the CSE.
Dec 23, 2021 08:56 pm ET
Medcolcanna Organics Inc. Announces Listing on the Canadian Securities Exchange and Delisting of Common Shares from The NEO
Bogota, Colombia--(Newsfile Corp. - December 23, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a Canadian integrated medical cannabis company with operations in Colombia, is pleased to announce that it has received approval to have the common shares of the Company ("Common Shares") listed on the Canadian Securities Exchange (the "CSE"). Consequently, the Company has also submitted a request to the Neo Exchange Inc. (the "NEO") to voluntarily delist the Common Shares from the NEO. The Company will be listing its Common Shares on the Canadian Securities Exchange (the "CSE") commencing at the opening of trading on December 30, 2021. The Common Shares are expected to be delisted from the Neo Exchange Inc. ("NEO") at close of business on December 29, 2021 and will begin trading on the CSE under the symbol "MCCN" at the opening bell on December 30, 2021. No action is required by shareholders in connection with this change of listing. For further information regarding the Company, please visit www.medcolcanna.com.
Dec 23, 2021 03:57 pm ET
CSE Bulletin: New Listing - Medcolcanna Organics Inc. (MCCN)
Toronto, Ontario--(Newsfile Corp. - Le 23 décembre/December 2021) The common shares of Medcolcanna Organics Inc. have been approved for listing on the CSE.
Dec 03, 2021 11:05 am ET
CSE Bulletin: New Listing - Medcolcanna Organics Inc. (MCCN)
Toronto, Ontario--(Newsfile Corp. - le 30 novembre/November 2021) - The common shares of Medcolcanna Organics Inc. have been approved for listing on the CSE.
Nov 25, 2021 07:00 am ET
Medcolcanna Organics Executes a Strategic Alliance Agreement with DNA Genetics
Bogota, Colombia--(Newsfile Corp. - November 25, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of a Strategic Alliance Agreement with DNA Genetics, a California based company with over 15 years of experience in bridging the gap to advance genetics in the cannabis industry.
Nov 12, 2021 10:51 pm ET
Medcolcanna Organics Announces Second Bridge Loan Arrangment and Second Closing of Equity Financing
Bogotá, Colombia--(Newsfile Corp. - November 12, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, announces a second bridge loan arrangement (the "Bridge Loan") with certain executive officers of the Company as well as some additional arm's length lenders (collectively, the "Lenders"). Under the terms of the Bridge Loan, the Lenders provided an initial bridge loan financing amount of $290,000 for a two-year term at an annual interest rate of 7.85%, with interest payments completed quarterly and with amortization of same commencing fifteen months from the date of the loan and with an additional $460,000 to be borrowed (the "Override Amount"), bringing the total available loan amount to $750,000. The purpose of the Bridge Loan is to cover working capital requirements, including payroll and related business expenses, until the Company can become financially self-sustaining.
Nov 04, 2021 08:25 am ET
Medcolcanna Organics Announces Issuance of Shares Pursuant to Various Corporate Transactions and First Closing of Equity Offering
Bogotá, Colombia--(Newsfile Corp. - November 4, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, announces a series of transactions resulting in the issuance of shares by the Company. The first transaction is a shares for debt transaction whereby the Company has issued an aggregate of 2,332,036 common shares in the capital of the Company ("Common Shares") with certain trade creditors and members of the Board of Directors in exchange for the forgiveness of a total amount of approximately $198,223 worth of debt owed to such creditors. The Common shares issued to certain trade creditors is for outstanding liabilities initially incurred from August 2020 to June 2021. The Common shares issued to the Board of Directors is for the director fees owed to all independent directors of the Company for the second quarter of 2021. The Common Shares were issued at a price of $0.085 per, such price being the 90 day volume weighted average trading price of the Common Shares on the facilities of the Neo Exchange Inc. leading up to and including June 30, 2021. The issuance of the Common Shares allows the Company to settle certain debt owing to various creditors and preserve its working capital for growing the business as it works towards achieving self-sufficiency and being self-financing. The Common Shares are subject to a four month and a day hold period under applicable securities laws, such hold expiring on March 4, 2022.
Oct 29, 2021 08:25 am ET
Medcolcanna Organics Inc. Announces Equity Financing
Bogota, Colombia--(Newsfile Corp. - October 29, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce that it intends to complete an offering of up to 10,000,000 common shares in the capital of the Company ("Common Shares") at a price of $0.05 per share for gross proceeds of up to $0.5 million (the "Offering"). Closing is expected to occur in early November. The Offering is non-brokered and is subject to approval of the Neo Exchange Inc. The Company intends to use the proceeds for general working capital as well as the purchase of raw materials for use in the business and to cover manufacturing costs for the Company's products.
Oct 20, 2021 08:30 am ET
Medcolcanna Organics Executes 60 Million US Dollar (74M CAD) Supply Agreement with US Based Industrial Hemp Farms
Bogota, Colombia--(Newsfile Corp. - October 20, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the signing and execution of a 5-year deal with Industrial Hemp Farms ("IHF"), one of the largest producers of hemp derived products in the world. This $12 Million USD ($14.9M CAD) a year deal ($60 M USD in total - $74.4M CAD over five years) follows the Colombian government's change in regulation this past July which allows Colombian licensed producers to export dried flower outside of the country.
Jun 08, 2021 07:00 am ET
MCCN Executes Extraction Agreement with Third-Party Cultivator
Bogota, Colombia--(Newsfile Corp. - June 8, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) (FSE: MO2) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of a long-term commercial extraction services agreement with La Finca Interactiva Arachna Inc. SAS ("La Finca"). La Finca is a Colombian based whole-owned subsidiary of Chemesis International Inc (C.CSI). The agreement is for MCCN to provide extraction services for La Finca.
Jun 04, 2021 05:03 pm ET
Medcolcanna Announces Mailing of Materials for AGM on July 7, 2021 and Provides Corporate Update
Bogota, Colombia--(Newsfile Corp. - June 4, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) (FSE: MO2) ("Medcolcanna", "MCCN" or the "Company"), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Wednesday, July 7, 2021 at 4:00 p.m. (Bogota time) at the offices of the Company will be held as a virtual meeting at the same time and on the same date.
Jun 01, 2021 07:00 am ET
MCCN Executes Extraction Agreement with International Cannabis Company
Bogota, Colombia--(Newsfile Corp. - June 1, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of an extraction service agreement with an International Cannabis Company, a company with formulations for health and wellness applications, for depression, anxiety and PTSD, which also has cultivation operations in Colombia.
May 27, 2021 07:00 am ET
Medcolcanna Organics Signs Landmark Agreement with Industry Leader Industrial Hemp Farms (IHF)
Bogota, Colombia--(Newsfile Corp. - May 27, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, is pleased to announce the execution of a Letter of Intent ("LOI") with Industrial Hemp Farms ( "IHF"), a large and well-established company based in Colorado, USA. The proposed business transaction is for the purchase of $1.0M USD ($1.2M CAD approx.) minimum of hemp derived high CBD dried flower per month. Pursuant to the LOI, other commodities will be also purchased from Medcolcanna by IHF.
May 14, 2021 07:19 pm ET
Medcolcanna Announces Postponement of AGM Scheduled for May 19, 2021
Bogotá, Colombia--(Newsfile Corp. - May 14, 2021) - Medcolcanna Organics Inc. (TSXV: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for Wednesday, May 19, 2021 at 11:00 a.m. (Bogota time) at the offices of the Company will be postponed to a later date, with details of the new date and time to be provided in a future news release. The Company expects that some of the items of business to be voted on may change and is therefore delaying the meeting in order to allow for the provision of new materials to the shareholders in conjunction with the meeting.
Mar 26, 2021 07:30 am ET
Medcolcanna Organics is Granted Approximately 4% of Worlds Legal Production Quota of Medical Cannabis
Bogota, Colombia--(Newsfile Corp. - March 26, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), an integrated cannabis company, announced today that the Colombian Government has granted the Company the authorization to manufacture psychoactive medical cannabis derivatives, which, according to the International Narcotics Control Board's publicly disclosed data, will account for the production of around ten percent of the country's total quota or approximately four percent of the total global quota for medicinal cannabis products in 2021.
Mar 24, 2021 05:30 pm ET
Medcolcanna Organics Announces Closing of Bridge Loan Arrangement
Bogota, Colombia--(Newsfile Corp. - March 24, 2021) -  Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Canadian and globally integrated medicinal cannabis company with operations in Colombia, announces an update with respect to the previously announced bridge loan arrangement with certain executive officers (the "Lenders") of the Company (the "Bridge Loan"), as more particularly set forth in the press releases dated Jan. 4, 2021 and Feb. 4 2021.
Mar 11, 2021 07:00 am ET
Medcolcanna Organics Announces Shares for Debt Transaction
Bogota, Colombia--(Newsfile Corp. - March 11, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, announces a shares for debt transaction whereby the Company has issued an aggregate of 3,837,440 common shares in the capital of the Company ("Common Shares") with certain trade creditors, employees and members of the Board of Directors in exchange for the forgiveness of a total amount of approximately $456,724.47 worth of debt owed to such creditors. A total of 1,812,764 of the Common Shares were issued at a price of $0.09 per share in exchange for the forgiveness of a total of approximately $163,150 worth of debt owing by the Company to some of its employees and members of the Board of Directors for director fees for Q3 and Q4 2020, such price being the 90 day volume weighted average trading price of the Common Shares on the facilities of the Neo Exchange Inc. leading up to and including March 5, 2021. The balance of the Common Shares issued (2,024,676) are priced at $0.145 per share, the value being settled at the market price of the Common Shares as of March 5, 2021, being the last trading day prior to the date where the valuation of such shares was determined, to certain vendors and suppliers as well as members of the Board of Directors for director fees for Q1 2021. The issuance of the Common Shares allows the Company to settle certain debt owing to various creditors and preserve its working capital for growing the business as it works towards achieving self-sufficiency and being self-financing. The Common Shares are subject to a four month hold under applicable securities laws, such hold expiring on July 11, 2021.
Mar 10, 2021 07:00 am ET
Medcolcanna Organics Inc. Signs Agreement of Magistral Formulations Distribution with Rappi
Bogotá, Colombia--(Newsfile Corp. - March 10, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a Canadian integrated medical cannabis company with operations in Colombia, is pleased to announce it has entered into a distribution agreement with the company responsible for the Rappi app for the distribution of MCCN's magistral formulations and to provide telemedicine services for the diagnosis and treatment of conditions and diseases with medicinal cannabis formulations.
Feb 11, 2021 07:30 am ET
Medcolcanna Organics Inc. Is Granted THC Psychoactive Quota to Be Used in Magistral Formulations and Other Medicinal Applications
Bogota, Colombia--(Newsfile Corp. - February 11, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a Canadian integrated medical cannabis company with operations in Colombia, is pleased to announce it has been granted a Psychoactive Quota for the production of THC Derivates by the Ministry of Health and Social Protection in Colombia. This comes as the result of Medcolcanna's ability to meet regulatory requirements and the Company's commitment to provide access to cannabis based medication to patients in Colombia.
Feb 04, 2021 07:30 am ET
Medcolcanna Organics Announces Bridge Loan Arrangement
Bogotá, Colombia--(Newsfile Corp. - February 4, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, announces an update with respect to the previously announced bridge loan arrangement with certain executive officers (the "Lenders") of the Company (the "Bridge Loan"), as more particularly set forth in the press release dated January 4, 2021. Under the terms of the Bridge Loan, the Lenders provided an initial bridge loan financing amount of $275,000 for a two-year term at an annual interest rate of 7.85%, with interest payments completed quarterly and with amortization of same commencing fifteen months from the date of the loan. Pursuant to recent amendments to the term of the Bridge Loan, an additional amount of $225,000 is to be made available pursuant to the Bridge Loan on or after January 21, 2021 with an option commencing that date and lasting until February 21, 2021 for an additional $250,000 (the "Override Amount"), bringing the total available loan amount to $750,000.
Jan 13, 2021 07:00 am ET
Medcolcanna Prepares for Recurring Commercial Shipments into Europe in 2021 and Provides Corporate Operational Update
Bogota, Colombia--(Newsfile Corp. - January 13, 2021) - Medcolcanna Organics Inc. (NEO: MCCN) ("Medcolcanna", "MCCN" or the "Company"), a leading Colombian and globally integrated cannabis company, is providing the following corporate update.
Jan 04, 2021 07:00 am ET
Medcolcanna Organics Announces Bridge Loan Arrangement
Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (NEO: MCCN), a leading Colombian and globally integrated cannabis company, announces a bridge loan arrangement with certain executive officers (the “Lenders”) of the Company (the...
Dec 24, 2020 06:30 am ET
Medcolcanna Organics Inc. Announces Closing of Upsized Convertible Debenture Financing
Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (NEO: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that it has closed on the second and final tranche of its previously announced...
Oct 15, 2020 08:12 am ET
Medcolcanna Organics Inc. Announces Financial Results for the Second Quarter of 2020
Medcolcanna Organics Inc. (“Medcolcanna” or “the “Company” or “MCCN”) (TSXV: MCCN) (FRA: MO2) announces the filing of its financial and operating results for the three and six months ended June 30, 2020. All dollar values in this news release and...
Oct 14, 2020 10:54 am ET
Medcolcanna Graduates Public Listing to NEO Exchange
NEO is pleased to announce it has granted final approval to Medcolcanna Organics Inc. (“Me
Oct 13, 2020 11:51 am ET
Medcolcanna Organics Inc. Announces Listing on The NEO Exchange And Delisting of Common Shares From The TSXV
Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (TSXV: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that, further to its press release dated September 25, 2020, the Company will be...
Sep 25, 2020 04:30 pm ET
Medcolcanna Organics Announces Final Approval for Listing of Common Shares on the NEO Exchange
Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (TSXV: MCCN), a Canadian integrated medical cannabis company with operations in Colombia, is pleased to announce that it has received final approval to have the common shares of the...
Sep 10, 2020 07:00 am ET
Medcolcanna Organics Inc. and Grupo Curativa SAS Enter Into a Joint Venture Agreement for the Development and Commercialization of Cannabis Based Pharmaceutical Products
Medcolcanna Organics Inc. (TSXV: MCCN), through its wholly-owned subsidiary Medcolcanna SAS (“Medcolcanna”, “MCCN” or the “Company”), a leading Colombian integrated cannabis company, is pleased to announce that it has entered into a joint venture...
Aug 28, 2020 07:30 am ET
Medcolcanna Organics Inc. Announces Closing of the First Tranche of Its Convertible Debenture Financing and Upsize to Offering
Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (TSXV: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that it has closed on the first tranche of its previously announced offering of...
Aug 21, 2020 04:15 pm ET
Medcolcanna Announces Extension of Filing Deadline of its Interim Financial Statements and MD&A
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, announces that due to the COVID-19 pandemic, the Company intends to postpone the filing of its unaudited...
Jul 20, 2020 07:30 am ET
Medcolcanna Organics Inc. Announces it Has Entered Into a Distribution Agreement, Has Secured Financing With Greenstein Capital Ltd.
Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the “Company”) (TSXV: MCCN), a leading Colombian and globally integrated cannabis company, is pleased to announce that it has entered into a distribution agreement with Greenstein Capital Ltd....
Jun 26, 2020 01:08 pm ET
IIROC Trading Resumption - MCCN
VANCOUVER, BC, June 26, 2020 /CNW/ - Trading resumes in:
Jun 26, 2020 12:11 pm ET
Medcolcanna Organics Inc. Announces Operational Update and Bridge Debenture Financing
Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or “the “Company”) (TSXV: MCCN), a leading Colombian and global integrated Cannabis Company, is pleased to provide an operational update and announce that it intends to proceed with a bridge...
Jun 26, 2020 11:50 am ET
IIROC Trading Halt - MCCN
VANCOUVER, BC, June 26, 2020 /CNW/ - The following issues have been halted by IIROC:
Jun 02, 2020 05:38 pm ET
Medcolcanna Organics Inc. Announces Financial Results for the Year Ended December 31, 2019 and for the First Quarter of 2020
Medcolcanna Organics Inc. (“Medcolcanna” or “the “Company”) (TSXV: MCCN) announces the filing of its annual financial and operating results for the year ended December 31, 2019 and for the three months ended March 31, 2020. All dollar values in...
May 19, 2020 07:29 pm ET
Medcolcanna Announces Change to Virtual Annual General Meeting on May 21, 2020
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, announces that its annual general and special meeting of holders of common shares scheduled for...
May 05, 2020 07:30 am ET
Medcolcanna Announces that Dona Blanca has Elected to Enter Stage 2 of the Joint Venture with Medcolcanna
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that, further to its press release dated April 7, 2020, Dona Blanca Limited...
Apr 27, 2020 08:29 pm ET
Medcolcanna Announces Extension of Filing Deadline of its Annual Financial Statements and MD&A and Other Corporate Matters
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, announces that due to the COVID-19 pandemic, the Company intends to postpone the filing of its annual...
Apr 24, 2020 07:00 am ET
Felipe de la Vega acquires Common Shares
Felipe de la Vega (the “Offeror”), a current insider of Medcolcanna Organics Inc. (the “Company”) by virtue of being an officer and director of the Company through his holdings personally as well as through shares held by his various holding...
Apr 07, 2020 07:30 am ET
Medcolcanna Executes Definitive Agreement for Joint Venture and extends LOI for Investment into Extraction Subsidiary
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna”, “MCCN” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that, further to its press release dated February 24, 2020, through its...
Feb 19, 2020 07:00 am ET
Medcolcanna Signs Letters of Intent for Joint Venture and Investment into Extraction Subsidiary
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that it has signed two (2) separate letters of intent (“LOIs”) with Dona Blanca...
Dec 02, 2019 08:32 pm ET
Medcolcanna Organics Inc. Announces Financial Results for the Third Quarter of 2019
Medcolcanna Organics Inc. (“Medcolcanna” or “the “Company”) (TSXV: MCCN) announces the filing of its financial and operating results on November 29, 2019 for the three and nine months ended September 30, 2019. All dollar values in this news release...
Nov 21, 2019 04:30 pm ET
Medcolcanna expands Global Leadership Team with Appointment of Chief Corporate Development Officer
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”) announces the expansion of its senior leadership team with the appointment of Daniel Herrera as Chief Corporate Development Officer. Daniel will lead Medcolcanna’s corporate...
Aug 29, 2019 05:30 pm ET
Medcolcanna Organics Inc. Announces Financial Results for Second Quarter of 2019
Medcolcanna Organics Inc. (the “Company” or “Medcolcanna”) (TSXV: MCCN) announces the filing of its financial and operating results for the three and six months ended June 30, 2019. All dollar values in this news release and the Company’s financial...
Aug 20, 2019 06:30 am ET
Medcolcanna Signs Licensing and Profit-Sharing Agreement with Herbolea Biotech for Patent Pending Technology
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that it has signed a Licensing and Processing Services Agreement with Herbolea Biotech...
Jul 25, 2019 06:30 am ET
Medcolcanna Signs Letter of Intent with Top Medical Center and Completes Purchase of Innovative CBD Products
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce that it has signed a Letter of Intent (“LOI”) with the University Medical Center...
Jun 11, 2019 06:30 am ET
Medcolcanna Strengthens Board of Directors with Addition of Pharmaceutical Executive
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce the appointment of Mr. José Joaquin Mora Hernandez to its Board of Directors as well...
May 30, 2019 06:30 am ET
Medcolcanna Enters Agreement to Acquire Interest in Cannabis Oil Refinery
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a Canadian medical cannabis company with operations in Colombia, is excited to announce that it has entered into a Master Agreement (the “Agreement”) with Greenstein Capital...
May 23, 2019 06:30 am ET
Medcolcanna Announces Commencement of Trading on the TSX Venture Exchange Under the Symbol MCCN and Other Corporate Matters
Medcolcanna Organics Inc. (TSX-V: MCCN) (“Medcolcanna” or the “Company”), a medical cannabis company operating in Colombia, is pleased to announce that its shares will begin trading on the TSX Venture Exchange (the “Exchange”) under the symbol...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.